|
|
|
| Application of Acupotomy in Improving Pain Degree and FRS and JOA Scores in Patients with Lumbar Disc Herniation |
| CHENG Yuesheng, HUANG Wenmiao, CAO Xiaoqin, ZHOU Zhujian, MAO Zhicheng, WANG Wei, CHEN Xuyu, WANG Difei |
| First-author's address: The Sixth People's Hospital of Jiujiang, Jiangxi Province, Jiujiang 332005, China |
|
|
|
|
Abstract Objective: To analyze and discuss the application of acupotomy in improving pain degree and function rating scale (FRS) and Japanese orthopaedic association scores (JOA) scores in patients with lumbar disc herniation. Method: A total of 174 patients with lumbar disc herniation who were admitted to the Sixth People's Hospital of Jiujiang from April 2020 to April 2022 were selected as the control group and the experimental group according to the random number table method, with 87 cases in each group. The control group was treated with hot compress with traditional Chinese medicine + manipulative reduction, and the experimental group was treated with acupotomy on the basis of the treatment of the control group. The patients were assessed with visual analogue scale (VAS), JOA and FRS for low back pain. The evaluation results and clinical efficacy of the two groups were compared. Result: The total effective rate of the experimental group was 97.70%, which was significantly higher than 80.46% of the control group (P<0.05). After 2 weeks of treatment and after treatment, the VAS scores of the experimental group respectively was (3.28±1.02), (2.02±0.28) scores, which were significantly lower than those of the control group (5.34±1.35), (3.65±0.85) scores at the same period (P<0.05). After 2 weeks of treatment and after treatment, the scores of JOA and FRS in both groups were significantly improved (P<0.05), and the scores of JOA and FRS in the experimental group were significantly better than those in the control group at the same period (P<0.05). Conclusion: Acupotomy therapy can relieve the pain of patients with lumbar disc herniation, improve the lumbar function and symptoms such as muscle strength decline and numbness.
|
|
Received: 01 December 2022
|
|
|
|
|
|
|
